Cover Image
市場調查報告書

全球代謝體學市場

Metabolomics

出版商 Global Industry Analysts, Inc. 商品編碼 210375
出版日期 內容資訊 英文 191 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球代謝體學市場 Metabolomics
出版日期: 2014年11月01日 內容資訊: 英文 191 Pages
簡介

本報告提供全球代謝體學市場相關調查,為您彙整市場2013∼2020年的預測,各產品區隔趨勢,各地區趨勢,及參與企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 代謝體學:目前"體學"toolbox的中心
    • 促進成長要素
    • 市場障礙與課題
    • 代謝體學:各地區預測
    • 歐美先導全球市場
    • 亞太地區:最快成長的市場
    • 生物科技,醫藥品部門推動代謝體學研究
    • 資料分析工具和軟體的需求增加 其他
  • 代謝體學應用趨勢
    • 藥物研發及毒性檢驗中急速落實
    • 代謝體學研究:潛在的標的驗證工具
    • 生物標記藥物研發的代謝分析受到關注
    • 腫瘤學:基於代謝體學的標記藥物研發之熱門領域
    • 個人化醫療上代謝體學所扮演的角色
    • 食品·營養領域代謝體學受到關注
    • 食品安全性檢驗的代謝分析
    • 全球食品安全問題
    • 生物科技和生物資訊學 其他
  • 分離,檢測技術趨勢
  • 產品概要
  • 研究開發
  • 產品引進/創新
  • 近幾年的產業活動
  • 參與企業
    • AB SCIEX (US)
    • Agilent Technologies, Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Chenomx, Inc.
    • humanmetaboromutekunorojizu株式會社
    • LECO Corporation
    • Metabolon, Inc.
    • Metanomics GmbH
    • 島津製作所株式會社
    • SiDMAP, LLC
    • Thermo Fisher Scientific, Inc.
    • Life Technologies Corp.
    • Waters Corporation
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6954

This report analyzes the worldwide markets for Metabolomics in US$ Million by the following Product Segments: Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 34 companies including many key and niche players such as -

AB SCIEX
Agilent Technologies, Inc.
Biocrates Life Sciences AG
Bio-Rad Laboratories, Inc.
Bruker Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Metabolomics

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Metabolomics - The Current Spotlight of "Omics" Toolbox
  • Growth Drivers
  • Market Barriers & Challenges
  • Metabolomics: A Regional Perspective
  • US and Europe Spearhead the Global Metabolomics Market
  • Asia-Pacific: The Fastest Growing Metabolomics Market
  • Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
  • Demand for Data Analysis Tools and Software on Rise
  • Bioinformatics-based Metabolomics Applications Poised to Grow
  • List of Select Metabolomic Analysis Software
  • Metabolomics Laboratory Management Systems (LIMS): Growing in Significance
  • Synopsis of Select Metabolomic Databases
  • Some Examples of Metabolomics LIMS
  • Targeted Metabolomics in Newborn Screening: An Area of Success
  • Lack of Standardization - A Prime Concern
  • Competitive Scenario

2. AN INSIGHT INTO METABOLOMICS APPLICATIONS

  • Metabolomics Gain Rapid Foothold in Drug Discovery and Toxicology Testing
  • Metabolomic Research - A Prospective Tool to Validate Potential Targets
  • Metabolite Profiling for Biomarker Discovery Gaining Prominence
    • Table 1: Global Biomarkers Market by Discovery Technology (2013): Percentage Share Breakdown for Bioinformatics, Imaging Technologies and Omics Technologies (includes corresponding Graph/Chart)
  • Oncology - A Key Focus Area for Metabolomics-Based Biomarker Discovery
    • Table 2: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 3: New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
    • Table 4: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
  • Role of Metabolomics in Personalized Medicine
    • Table 5: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 6: %Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)
  • Food & Nutrition Looks Up to Metabolomics
  • Metabolomic Profiling in Food Safety Testing: An Opportunity to Tap
  • Global Food Safety Concerns: A Review
  • Biotechnology and Bioinformatics - The Backbone of New Testing Technologies
  • Plants and Agriculture: Metabolomics to Play a Vital Role
  • Metabolites Present in Select Agricultural Crops
  • Metabolomics Research on Tomato and Potato Crops
  • Metabolomics for Environmental Sciences
  • Nutrigenomics to Benefit from Metabolomics Approach

3. AN INSIGHT INTO SELECT SEPARATION AND DETECTION TECHNOLOGIES

  • A Primer...
  • Separation and Detection Techniques: A Review
  • Separation Techniques
    • Gas chromatography (GC)
    • Capillary Electrophoresis (CE)
    • High Performance Liquid Chromatography (HPLC)
    • Ultra Performance Liquid Chromatography (UPLC)
  • Detection Techniques
    • Mass spectrometry (MS)
    • Nuclear Magnetic Resonance (NMR) Spectroscopy (NMR)
    • Surface-based Mass Analysis
      • Common and Prospective Technologies in Metabolite Profiling
  • Noteworthy Trends
  • High Performance Liquid Chromatography (HPLC) Dominates the Market
  • Major Trends in Gas Chromatography: A Quick Review
  • Advances in GC Technology
  • Hyphenated Technologies: Order of the Day
  • Liquid Chromatography Gains Space in Metabolomics Analysis
  • MS Systems with UHPLC: A Novel Fusion
  • HILIC Systems Soaring in Popularity
  • Capillary Electrophoresis Gains Prominence

4. PRODUCT OVERVIEW

  • Metabolomics - Introduction
  • Metabolome
  • Metabolites
  • Metabolomics Evolution over the Years
  • Metabolomics Vs. Metabonomics
  • Analytical Methods
  • Key Application Areas
  • Toxicity Assessment/Toxicology
  • Functional Genomics
  • Nutrigenomics
  • Conceptual Approaches in Metabolomics
  • Target Analysis
  • Metabolite Profiling
  • Metabolomics
  • Metabolic Fingerprinting
  • Technological Advancements in Metabolomics
  • Metabolomics as Systems Biology Tool
  • Metabolomics: A Link between Genetics and Ecology
  • Limitations
  • An Overview of Metabolomics Research
  • Adoption of Metabolomics Research by Type of Entity
  • Implementation of Metabolomics Research by Nature of Study
  • Implementation of Metabolomics Research by Type of Laboratory
  • Key Issues Associated with Metabolomics Study

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • BIOCRATES Life Sciences Introduces Metabolomics-based Bile Acids Kit
  • Waters Corporation Releases New Data Analysis Software Packages for Proteomics and Metabolomics/Lipidomics Analyses
  • Researchers Demonstrates Biocrates' AbsoluteIDQ p180 Metabolomics Test Kit to Predict Alzheimer's Disease
  • Metabolon Introduces Quantose IR™ Prediabetes Test
  • Metabolon Rolls Out Fourth Generation DiscoveryHD4™ Metabolomics Platform
  • Bruker Introduces Next-Generation GC-APCI II GC-MS Interface with Automatic MS Calibration
  • Bruker Introduces MS-based Solutions and Systems
  • Metabolon Announces Expansion of Biochemical Profiling Capabilities
  • Health Diagnostic Laboratory Introduces Quantose™-based New Diabetes Prevention & Management Panel
  • Bruker Launches COMPACT LC-QqTOF Mass Spectrometer
  • BIOCRATES to Introduce Thermo Edition of AbsoluteIDQ® p150
  • Shimadzu Introduces GC/MS Metabolite Database Ver. 2
  • Shimadzu Releases New LC/MS/MS Method Package for Primary Metabolites
  • BIOCRATES Life Sciences to Introduce Waters Xevo® TQ MS Editions for AbsoluteIDQ® p180 und p150

6. RECENT INDUSTRY ACTIVITY

  • Metabolon Collaborates with Metdia Biotech
  • Metabolon and Baylor College of Medicine Collaborate to Launch Global MAPS for Inborn Errors of Metabolism
  • Metabolomic Diagnostic Secures €750,000 Seed Investment
  • Metabolon Enters into Collaboration with GlaxoSmithKline
  • Metabolomic Discoveries Enters into Distributorship Agreement with Filgen
  • Metabolon Inks Collaboration Agreement with Human Longevity
  • Metabolon Collaborates with the Carlos Slim Institute, Clinica Ruiz and Patia
  • Global Genomics Group to Partner with Metabolon
  • Human Metabolome Technologies Secures Patent for Method of Measuring Ethanolamine Phosphate
  • Metabolon and Bostwick Laboratories Enter into Marketing Agreement
  • IMDEA Food Collaborates with Metabolon to Advance Nutrition-based Personalized Medicine
  • University of Alberta, BGI Shenzhen and MTI Collaborate to Commercialize PolypDx™ Metabolomic-based Diagnostic Test
  • Agilent Technologies Collaborates with DGIST on Neurometabolomics Research
  • DHMRI Enters into Strategic Alliance with Metabolon
  • AB SCIEX, Genedata, and LECO Enter into Technology Partnership
  • Matrix-Bio Enters into Metabolomics Biomarker Licensing Agreement with Quest
  • Chenomx Collaborates with Spain's Centre for Omic Sciences
  • Agilent Collaborates with Spain's Centre for Omic Sciences
  • Metabolon Renews Multi-Year Agreement with Syngenta
  • Human Metabolome Technologies Inaugurates New Office in the US
  • LECO Enters into Agreement with DOE's Lawrence Berkeley National Laboratory
  • Metabolon Acquires Lipomics Technologies
  • Takeda and Metabolon Enter into Long-Term Research Alliance
  • Biocrates Enters into Distribution and Co-Marketing Agreement with MATERLAB and ONKOGEN Diagnostik
  • Waters and Nonlinear Dynamics Enter into Agreement to Co-Develop New Analytical Solution

7. FOCUS ON SELECT PLAYERS

  • AB SCIEX (US)
  • Agilent Technologies, Inc. (US)
  • Biocrates Life Sciences AG (Austria)
  • Bio-Rad Laboratories, Inc. (US)
  • Bruker Corporation (US)
  • Chenomx, Inc. (Canada)
  • Human Metabolome Technologies, Inc. (Japan)
  • LECO Corporation (US)
  • Metabolon, Inc. (US)
  • Metanomics GmbH (Germany)
  • Shimadzu Corporation (Japan)
  • SiDMAP, LLC (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Life Technologies Corp. (US)
  • Waters Corporation (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
    • Table 9: World 13-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)
    • Table 10: World Recent Past, Current & Future Analysis for Metabolomics by Segment - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Metabolomics by Segment - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
    • Table 12: World 13-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Revenues for Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Strong Emphasis on Metabolomics Research
    • Personalized Medicine - An Opportunity for Metabolomics Technology
    • Product Introductions/Innovations
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 13: US Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 14: US Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Chenomx, Inc. - A Key Player
  • B. Market Analytics
    • Table 15: Canadian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 16: Canadian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 17: Japanese Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 18: Japanese Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Personalized Medicine: Opportunities for Growth
    • Table 19: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 20: European Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 21: European Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
    • Table 22: European 13-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 23: French Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 24: French Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Metanomics GmbH - A Key Player
  • B. Market Analytics
    • Table 25: German Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 26: German Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 27: Italian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: Italian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analysis
    • Table 29: UK Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 30: UK Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Austria
    • Finland
    • Product Introductions/Innovations
    • Strategic Corporate Developments
    • Biocrates Life Sciences AG (Austria) - A Major Player
  • B. Market Analytics
    • Table 31: Rest of Europe Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Rest of Europe Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Australia
      • University of Melbourne at the Forefront of Metabolomics Research
  • B. Market Analytics
    • Table 33: Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Asia-Pacific Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 35: Latin American Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Latin American Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 37: Rest of World Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 38: Rest of World Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top